HDL Assist
Withdrawn from the US market on 30 September 2019 (according to the DSLD)
Enzymatic Therapy, food supplement from the US market
Label withdrawn from the US market. HDL Assist (Enzymatic Therapy), a food supplement au code-barres 763948029228, is described by its US market label. If sold in France, it would be subject to 3 points of French or European regulation, detailed below. Doses of folates, niacine are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 296 mg a day according to the label (at most 2 servings a day), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 6 mg a day according to the label (at most 2 servings a day), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Sélénium: up to 98 µg a day according to the label (at most 2 servings a day), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Enzymatic Therapy
- Barcode
- 763948029228
- Form
- Tablet
- One serving
- 2 tablets
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Cellulose, Stearic Acid, Silicon Dioxide, Sodium Croscarmellose, Maltodextrin, Magnesium Stearate, Methylcellulose, Glycerin, Carnauba wax
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Calories | Other | 5 Calorie(s) |
| Total Carbohydrates | Carbohydrate | not stated |
| Dietary Fiber | Fibre | not stated |
| Vitamin C | Vitamin | 148 mg |
| Vitamin E | Vitamin | 34 UI |
| Niacin | Vitamin | 20 mg |
| Vitamin B6 | Vitamin | 3 mg |
| Folate | Vitamin | 300 µg |
| Vitamin B12 | Vitamin | 19 µg |
| Magnesium | Mineral | 10 mg |
| Selenium | Mineral | 49 µg |
| Proprietary Blend | Blend | 419 mg |
| Taurine | Other substance | not stated |
| Hawthorn leaf and flower extract | Plant | not stated |
| Garlic (Allium sativum) | Plant | not stated |
| Soy seed isoflavones | Other substance | not stated |
| N-Acetylcysteine | Other substance | not stated |
| Grape seed extract | Plant | not stated |
| Red Wine extract | Other | not stated |
| Alpha Lipoic Acid | Other substance | not stated |
| Tocotrienols | Vitamin | not stated |
| L-Arginine | Amino acid | 153 mg |
| L-Carnitine | Other substance | 50 mg |
| Coenzyme Q10 | Other substance | 24 mg |
| Policosanol | Other substance | 7 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: HDL ASSIST
Entered into DSLD on 22 December 2017. Withdrawn from the US market on 21 June 2018 (according to the DSLD).- Active ingredient added : Garlic extract (quantity not stated)
- Active ingredient added : Grape skin extract (quantity not stated)
- Active ingredient added : Hawthorn (quantity not stated)
- Active ingredient added : Soy Isoflavones (quantity not stated)
- Active ingredient added : W-Acetylcysteine (quantity not stated)
- Active ingredient removed : Garlic (quantity not stated)
- Active ingredient removed : Hawthorn leaf and flower extract (quantity not stated)
- Active ingredient removed : N-Acetylcysteine (quantity not stated)
- Active ingredient removed : Red Wine extract (quantity not stated)
- Active ingredient removed : Soy seed isoflavones (quantity not stated)
- Same quantity, different name: Folic Acid in this version; Folate on the displayed label (300 mcg)
- Different quantity per serving : Coenzyme Q10: 25 mg in this version; 24 mg on the displayed label
- Different quantity per serving : Proprietary Blend: 388 mg in this version; 419 mg on the displayed label
- Different quantity per serving : Vitamin B12: 20 mcg in this version; 19 mcg on the displayed label
- Different quantity per serving : Vitamin E: 35 IU in this version; 34 IU on the displayed label
Official label: HDL ASSIST
Entered into DSLD on 23 December 2015. Withdrawn from the US market on 8 February 2017 (according to the DSLD).- Active ingredient added : Grape skin extract (quantity not stated)
- Active ingredient added : Hawthorn berry extract (quantity not stated)
- Active ingredient added : Soy Isoflavones (quantity not stated)
- Active ingredient removed : Hawthorn leaf and flower extract (quantity not stated)
- Active ingredient removed : Red Wine extract (quantity not stated)
- Active ingredient removed : Soy seed isoflavones (quantity not stated)
- Same quantity, different name: Folic Acid in this version; Folate on the displayed label (300 mcg)
- Different quantity per serving : Coenzyme Q10: 25 mg in this version; 24 mg on the displayed label
- Different quantity per serving : Proprietary Blend: 388 mg in this version; 419 mg on the displayed label
- Different quantity per serving : Vitamin B12: 20 mcg in this version; 19 mcg on the displayed label
- Different quantity per serving : Vitamin E: 35 IU in this version; 34 IU on the displayed label
- Different unit, without conversion : Calories: 5 {Calories} in this version; 5 Calorie(s) on the displayed label
- Quantity stated differently, without estimation : Total Carbohydrates: 1 Gram(s) in this version; < 1 Gram(s) on the displayed label
Official label: HDL Booster
Entered into DSLD on 25 November 2014. Withdrawn from the US market on 9 November 2015 (according to the DSLD).- Active ingredient added : Grape (Vitis vinifera) seed extract (quantity not stated)
- Active ingredient added : Hawthorn (Crateagus oxyacantha Berry) Extract (quantity not stated)
- Active ingredient added : Soy Isoflavones (quantity not stated)
- Active ingredient removed : Coenzyme Q10 (24 mg)
- Active ingredient removed : Grape seed extract (quantity not stated)
- Active ingredient removed : Hawthorn leaf and flower extract (quantity not stated)
- Active ingredient removed : L-Arginine (153 mg)
- Active ingredient removed : L-Carnitine (50 mg)
- Active ingredient removed : Policosanol (7 mg)
- Active ingredient removed : Red Wine extract (quantity not stated)
- Active ingredient removed : Soy seed isoflavones (quantity not stated)
- Same quantity, different name: Folic Acid in this version; Folate on the displayed label (300 mcg)
- Different quantity per serving : Proprietary Blend: 388 mg in this version; 419 mg on the displayed label
- Different quantity per serving : Vitamin B12: 20 mcg in this version; 19 mcg on the displayed label
- Different quantity per serving : Vitamin E: 35 IU in this version; 34 IU on the displayed label
- Different unit, without conversion : Calories: 5 {Calories} in this version; 5 Calorie(s) on the displayed label
- Quantity stated differently, without estimation : Total Carbohydrates: 1 Gram(s) in this version; < 1 Gram(s) on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Taurine
Read the warning, when it applies and the studies cited
TAURINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).
Sources cited by Health Canada (2)
- López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
- Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Garlic
Read the warning, when it applies and the studies cited
Garlic - Allium sativum
Route of administration: Oral
Cautions and warnings
Condition of application: Relief of upper respiratory tract infections and catarrhal (nasal congestion) conditions.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All uses.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or protease inhibitors (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- N-Acetylcysteine
Read the warning, when it applies and the studies cited
N-ACETYL-L-CYSTEINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney stones (Fauci et al. 1998; Mårtensson et al. 1990).
Sources cited by Health Canada (2)
- Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DI, Hauser SL and Longo DL, editors. Harrison's Principles of Internal Medicine, 14th edition. Toronto (ON): McGraw-Hill Health Professions Division; 1998.
- Mårtensson J, Denneberg T, Lindell Å, Textorius O. Sulfur amino acid metabolism in cystinuria : A biochemical and clinical study of patients. Kidney International 1990;37:143-149. PubMed
Contraindications
Do not use if you are taking antibiotics or nitroglycerin (Repchinsky 2008; Cederlund and Märdh 1993; Parry and Neu 1977; Ardissino et al. 1997).
Sources cited by Health Canada (4)
- Ardissino D, Merlini PA, Savonitto S, Demicheli G, Zanini P, Bertocchi F, Falcone C, Ghio S, Marinoni G, Montemartini C, Mussini A. Effect of transdermal nitroglycerin or N- acetylcysteine, or both, in the long-term treatment of unstable angina pectoris. Journal of the American College of Cardiology 1997;29(5):941-947. PubMed Randomised trial
- Cederlund H, Märdh PA. Antibacterial activities of non-antibiotic drugs. Journal of Antimicrobial Chemotherapy 1993;32:355-365. PubMed Review article
- Parry MF, Neu HC. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. Journal of Clinical Microbiology 1977;5(1);58-61.
- Repchinsky C, editor. Compendium of Pharmaceuticals and Specialties. The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.
- L-Carnitine
Read the warning, when it applies and the studies cited
L-CARNITINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a seizure disorder (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.
- Coenzyme Q10
Read the warning, when it applies and the studies cited
Coenzyme Q10 (UBIQUINONE-10)
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).
Sources cited by Health Canada (2)
- Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
- Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial
Applies to products providing more than 100 mg of Coenzyme Q10 per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).
Sources cited by Health Canada (3)
- Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
- Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
- Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report
Condition of application: Migraine prophylaxis/prevention.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Enzymatic Therapy
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “HDL Assist : étiquette retirée du marché américain (Enzymatic Therapy): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/763948029228-hdl-assist-enzymatic-therapy, updated 30 September 2019.